title: Polymyalgia rheumatica: clinical update.
abstract: BACKGROUND
  Polymyalgia rheumatica is a relatively common inflammatory rheumatic disease. There are no validated international guidelines available for the diagnosis and treatment of PMR; however, diagnostic and classification criteria are currently being developed.
  
  
  OBJECTIVE
  The aim of this article is to summarise the main management options suggested by American College of Rheumatology and discusses the role of the general practitioner in the diagnosis and early management of PMR.
  
  
  CONCLUSIONS
  Diagnosis is made on the basis of a combination of clinical and laboratory findings. Patients typically present with shoulder and hip girdle pain with pronounced stiffness. Inflammatory markers are usually elevated and an ultrasound and MRI of the shoulder and hip can be done to localise inflamed tissues. Response to steroids should not be used as a defining feature of PMR but treatment with low dose prednisone should be considered. PMR has an excellent prognosis if diagnosis is prompt and therapy adequate.
authors.affiliation: FRACP, Senior Advanced Trainee Registrar, Thoracic Medicine, Royal Adelaide Hospital, and Clinical Associate Lecturer, Discipline of Medicine, University of Adelaide, SA.
authors.forename: Faisal
authors.initials: F
authors.lastname: Ameer
authors.forename: Julian
authors.initials: J
authors.lastname: McNeil
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D015415:Biomarkers; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000378:metabolism; D006801:Humans; D011111:Polymyalgia Rheumatica / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D002097:C-Reactive Protein